 Live Webcast Presentation on Wednesday, May 25th at 4:00 PM ET FRAMINGHAM, MA ACCESSWIRE May 18, 2022 Xenetic Biosciences, Inc. NASDAQ:XBIO Xenetic or the Company, a biopharmaceutical company focused on advancing innovative immune-oncology technologies for the treatment of hard to treat cancers, today announced that Jeffrey F. Eisenberg, Chief Executive Officer of Xenetic, will present at the H.C. 